Calcium and contribution to the normal development of bones: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006: (Scientific Opinion)

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)

doi:10.2903/j.efsa.2016.4587

Calcium and contribution to the normal development of bones: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006: (Scientific Opinion)

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)

Obesity Research

138 Downloads (Pure)

Abstract

Following an application from Specialised Nutrition Europe (formerly IDACE), submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to calcium and
contribution to the normal development of bones. The Panel considers that calcium is sufficiently characterised and that contribution to the normal development of bones is a beneficial physiological effect. The target population proposed by the applicant is infants (from birth) and young children up to 3 years of age. The Panel has previously assessed a claim on calcium and normal growth and development of bone with a favourable outcome. The target population was children and adolescents. The Panel considers that the role of calcium in the development of bones applies to all ages including infants and young children up to 3 years of age. The Panel concludes that a cause and effect
relationship has been established between the dietary intake of calcium and contribution to the normal development of bones.

Original language	English
Article number	4587
Journal	E F S A Journal
Volume	14
Issue number	10
Number of pages	9
ISSN	1831-4732
DOIs	https://doi.org/10.2903/j.efsa.2016.4587
Publication status	Published - 20 Oct 2016

Keywords

Faculty of Science
Calcium
Infants
Children
Bones
Health claims

Access to Document

10.2903/j.efsa.2016.4587Licence: CC BY

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (Sjodin)_EFSA Journal_2016_Vol 14(10)_4587Final published version, 592 KBLicence: CC BY

Cite this

Calcium and contribution to the normal development of bones: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 : (Scientific Opinion). / EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA).

In: E F S A Journal, Vol. 14, No. 10, 4587, 20.10.2016.

Research output: Contribution to journal › Journal article › Commissioned › peer-review

@article{c679da7396284fc99398c31d21ff9fd5,

title = "Calcium and contribution to the normal development of bones: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006: (Scientific Opinion)",

abstract = "Following an application from Specialised Nutrition Europe (formerly IDACE), submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to calcium andcontribution to the normal development of bones. The Panel considers that calcium is sufficiently characterised and that contribution to the normal development of bones is a beneficial physiological effect. The target population proposed by the applicant is infants (from birth) and young children up to 3 years of age. The Panel has previously assessed a claim on calcium and normal growth and development of bone with a favourable outcome. The target population was children and adolescents. The Panel considers that the role of calcium in the development of bones applies to all ages including infants and young children up to 3 years of age. The Panel concludes that a cause and effectrelationship has been established between the dietary intake of calcium and contribution to the normal development of bones.",

keywords = "Faculty of Science, Calcium, Infants, Children, Bones, Health claims",

author = "Sj{\"o}din, {Anders Mikael} and {EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)}",

note = "EFSA 2016 4587",

year = "2016",

month = oct,

day = "20",

doi = "10.2903/j.efsa.2016.4587",

language = "English",

volume = "14",

journal = "E F S A Journal",

issn = "1831-4732",

publisher = "European Food Safety Authority (E F S A)",

number = "10",

}

TY - JOUR

T1 - Calcium and contribution to the normal development of bones: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006

T2 - (Scientific Opinion)

AU - Sjödin, Anders Mikael

AU - EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)

N1 - EFSA 2016 4587

PY - 2016/10/20

Y1 - 2016/10/20

N2 - Following an application from Specialised Nutrition Europe (formerly IDACE), submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to calcium andcontribution to the normal development of bones. The Panel considers that calcium is sufficiently characterised and that contribution to the normal development of bones is a beneficial physiological effect. The target population proposed by the applicant is infants (from birth) and young children up to 3 years of age. The Panel has previously assessed a claim on calcium and normal growth and development of bone with a favourable outcome. The target population was children and adolescents. The Panel considers that the role of calcium in the development of bones applies to all ages including infants and young children up to 3 years of age. The Panel concludes that a cause and effectrelationship has been established between the dietary intake of calcium and contribution to the normal development of bones.

AB - Following an application from Specialised Nutrition Europe (formerly IDACE), submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to calcium andcontribution to the normal development of bones. The Panel considers that calcium is sufficiently characterised and that contribution to the normal development of bones is a beneficial physiological effect. The target population proposed by the applicant is infants (from birth) and young children up to 3 years of age. The Panel has previously assessed a claim on calcium and normal growth and development of bone with a favourable outcome. The target population was children and adolescents. The Panel considers that the role of calcium in the development of bones applies to all ages including infants and young children up to 3 years of age. The Panel concludes that a cause and effectrelationship has been established between the dietary intake of calcium and contribution to the normal development of bones.

KW - Faculty of Science

KW - Calcium

KW - Infants

KW - Children

KW - Bones

KW - Health claims

U2 - 10.2903/j.efsa.2016.4587

DO - 10.2903/j.efsa.2016.4587

M3 - Journal article

SN - 1831-4732

VL - 14

JO - E F S A Journal

JF - E F S A Journal

IS - 10

M1 - 4587

ER -

Calcium and contribution to the normal development of bones: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006: (Scientific Opinion)

Abstract

Keywords

Access to Document

Fingerprint

Cite this